Clinical Trials

100+ Companies
Companies
116
Growing
Deals 2022 Q2
No investments
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
MedCity News

Sanofi drops out of competitive breast cancer drug race after another trial failure

Pulse 2.0

Ainos (AIMD) Stock: Why It Increased Over 20% Today

MedCity News

New funding fuels device-maker’s pursuit of FDA approval

MIT Technology Review

These scientists are working to extend the life span of pet dogs—and their owners

Pulse 2.0

Plus Therapeutics (PSTV) Stock: Why It Surged Over 50% Today

MedCity News

AstraZeneca & Daiichi drug wins another FDA approval, this time in lung cancer

MedCity News

Novartis warns of two patients deaths after dosing with gene therapy Zolgensma

Pulse 2.0

Timber Pharmaceuticals (TMBR) Stock: Why It Fell Over 13% Today

Pulse 2.0

Cyclacel Pharmaceuticals (CYCC) Stock: Why It Surged Over 30% Today

MedCity News

Aduhelm’s loss is a win for value-based drug pricing

GeekWire

Fred Hutch spinout lands $10M for precision test to guide cancer treatment, develop drugs

MedCity News

FDA turns down Acadia Pharma drug for Alzheimer’s psychosis; new trial needed

Fast Company

How human ‘organs on a chip’ can help replace animal testing

MedCity News

Disappointing data lead Pfizer to drop heart drug acquired as part of $11B deal

Labiotech.eu

Novavax starts COVID-19 vaccine trial for children aged six months to 11 years

MedCity News

Clinical trial sponsors need to take into consideration pandemic burnout

MedCity News

Aiming to bring drug combos into earlier lines of cancer therapy, IDRx lands $122M

MedCity News

FDA hits pause on Beam Therapeutics’ off-the-shelf cell therapy for blood cancers

MedCity News

Who won INVEST PharmaTech Pitch Perfect contest?

MedCity News

The importance of patient centricity in healthcare